331 related articles for article (PubMed ID: 15614426)
41. Differentiaton of neuropharmacological actions of apomorphine and d-amphetamine.
Quock RM; Horita A
Pharmacol Biochem Behav; 1976 Dec; 5(6):627-31. PubMed ID: 139615
[TBL] [Abstract][Full Text] [Related]
42. Effects of short- and long-acting dopamine agonists on sensitized dopaminergic neurotransmission in rats with unilateral 6-OHDA lesions.
Kashihara K; Manabe Y; Murakami T; Abe K
Life Sci; 2002 Jan; 70(9):1095-100. PubMed ID: 11860157
[TBL] [Abstract][Full Text] [Related]
43. Neuroprotective effects of the alpha2-adrenoceptor antagonists, (+)-efaroxan and (+/-)-idazoxan, against quinolinic acid-induced lesions of the rat striatum.
Martel J; Chopin P; Colpaert F; Marien M
Exp Neurol; 1998 Dec; 154(2):595-601. PubMed ID: 9878194
[TBL] [Abstract][Full Text] [Related]
44. Entacapone potentiates the long-duration response but does not normalize levodopa-induced molecular changes.
Marin C; Aguilar E; Mengod G; Cortés R; Rodríguez-Oroz MC; Obeso JA
Neurobiol Dis; 2008 Dec; 32(3):340-8. PubMed ID: 18722529
[TBL] [Abstract][Full Text] [Related]
45. Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Henry B; Crossman AR; Brotchie JM
Exp Neurol; 1998 Jun; 151(2):334-42. PubMed ID: 9628768
[TBL] [Abstract][Full Text] [Related]
46. Interaction between the noradrenergic and serotonergic systems in locomotor hyperactivity and striatal expression of Fos induced by amphetamine in rats.
Muñoz A; Lopez-Real A; Labandeira-Garcia JL; Guerra MJ
Exp Brain Res; 2003 Nov; 153(1):92-9. PubMed ID: 12955385
[TBL] [Abstract][Full Text] [Related]
47. Effects of d-amphetamine on the frequency of the spontaneous contraction of the portal vein in rat.
Wu NY; Chen YH; Huang SS; Tsai MC
Gen Pharmacol; 1998 May; 30(5):669-83. PubMed ID: 9559317
[TBL] [Abstract][Full Text] [Related]
48. Effect of desipramine and amphetamine on noradrenergic neurotransmission: electrophysiological studies in the rat brain.
Curet O; De Montigny C; Blier P
Eur J Pharmacol; 1992 Oct; 221(1):59-70. PubMed ID: 1333978
[TBL] [Abstract][Full Text] [Related]
49. Risperidone inhibits 5-hydroxytryptaminergic neuronal activity in the dorsal raphe nucleus by local release of 5-hydroxytryptamine.
Hertel P; Nomikos GG; Svensson TH
Br J Pharmacol; 1997 Dec; 122(8):1639-46. PubMed ID: 9422809
[TBL] [Abstract][Full Text] [Related]
50. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
Boronat MA; Olmos G; García-Sevilla JA
Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
[TBL] [Abstract][Full Text] [Related]
51. Locomotor hyperactivity induced by MK-801 in rats.
Maj J; Rogóz Z; Skuza G
Pol J Pharmacol Pharm; 1991; 43(6):449-58. PubMed ID: 1687944
[TBL] [Abstract][Full Text] [Related]
52. Clozapine reversal of the deficits in coordinated movement induced by D2 receptor blockade does not depend upon antagonism of alpha2 adrenoceptors.
McAllister KH; Rey B
Naunyn Schmiedebergs Arch Pharmacol; 1999 Dec; 360(6):603-8. PubMed ID: 10619175
[TBL] [Abstract][Full Text] [Related]
53. 3,4-Methylenedioxymethamphetamine counteracts akinesia enantioselectively in rat rotational behavior and catalepsy.
Lebsanft HB; Kohles T; Kovar KA; Schmidt WJ
Synapse; 2005 Mar; 55(3):148-55. PubMed ID: 15602749
[TBL] [Abstract][Full Text] [Related]
54. Phencyclidine-induced deficits in prepulse inhibition of startle are blocked by prazosin, an alpha-1 noradrenergic antagonist.
Bakshi VP; Geyer MA
J Pharmacol Exp Ther; 1997 Nov; 283(2):666-74. PubMed ID: 9353384
[TBL] [Abstract][Full Text] [Related]
55. Antagonism of drug-induced yawning and penile erections in rats.
Gower AJ; Berendsen HH; Broekkamp CL
Eur J Pharmacol; 1986 Mar; 122(2):239-44. PubMed ID: 2872065
[TBL] [Abstract][Full Text] [Related]
56. Potentiation of dopamine receptor-mediated responses by B-HT 920 in mice.
Chopra K; Kulkarni SK
Arch Int Pharmacodyn Ther; 1988; 294():46-55. PubMed ID: 2906798
[TBL] [Abstract][Full Text] [Related]
57. Pharmacological characterization and autoradiographic distribution of alpha2-adrenoceptor antagonist [3H]RX 821002 binding sites in the chicken brain.
Díez-Alarcia R; Pilar-Cuéllar F; Paniagua MA; Meana JJ; Fernández-López A
Neuroscience; 2006 Aug; 141(1):357-69. PubMed ID: 16697114
[TBL] [Abstract][Full Text] [Related]
58. Conditioned rotational behavior in rats with unilateral 6-hydroxydopamine lesions of the substantia nigra.
Carey RJ
Brain Res; 1986 Feb; 365(2):379-82. PubMed ID: 3081236
[TBL] [Abstract][Full Text] [Related]
59. Priming of rotational behavior by a dopamine receptor agonist in Hemiparkinsonian rats: movement-dependent induction.
Simola N; Di Chiara G; Daniels WM; Schallert T; Morelli M
Neuroscience; 2009 Feb; 158(4):1625-31. PubMed ID: 19063947
[TBL] [Abstract][Full Text] [Related]
60. Study into a possible mechanism responsible for the antidepressant-like activity of the selective 5-HT6 receptor antagonist SB-399885 in rats.
Wesołowska A
Pharmacol Rep; 2007; 59(6):664-71. PubMed ID: 18195455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
